Trials / Conditions / Autoimmune Lymphoproliferative Syndrome
Autoimmune Lymphoproliferative Syndrome
4 registered clinical trials studyying Autoimmune Lymphoproliferative Syndrome — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Study of the ITK Inhibitor Soquelitinib to Reduce Lymphoproliferation and Improve Cytopenias in Autoimmune Lym NCT06730126 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Recruiting | Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflamma NCT04902807 | Institut National de la Santé Et de la Recherche Médicale, France | — |
| Active Not Recruiting | Immune Disorder HSCT Protocol NCT01821781 | Washington University School of Medicine | Phase 2 |
| Withdrawn | Fluorodeoxyglucose Imaging Studies to Detect Lymphoma NCT01672918 | National Institute of Allergy and Infectious Diseases (NIAID) | — |